Citadel Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-112,981
Closed -$5.84M 7258
2022
Q3
$5.84M Sell
112,981
-191,443
-63% -$9.89M ﹤0.01% 1722
2022
Q2
$7.54M Sell
304,424
-1,906
-0.6% -$47.2K ﹤0.01% 1488
2022
Q1
$7.68M Sell
306,330
-234,282
-43% -$5.87M ﹤0.01% 1656
2021
Q4
$19.7M Sell
540,612
-419,075
-44% -$15.3M ﹤0.01% 946
2021
Q3
$16.4M Buy
959,687
+237,548
+33% +$4.06M ﹤0.01% 1047
2021
Q2
$9.67M Buy
722,139
+378,759
+110% +$5.07M ﹤0.01% 1473
2021
Q1
$17.6M Sell
343,380
-229,691
-40% -$11.8M ﹤0.01% 1012
2020
Q4
$35.5M Buy
573,071
+114,846
+25% +$7.11M 0.01% 580
2020
Q3
$25.1M Sell
458,225
-300,013
-40% -$16.4M 0.01% 652
2020
Q2
$43.6M Buy
758,238
+23,813
+3% +$1.37M 0.02% 426
2020
Q1
$29.5M Buy
734,425
+673,474
+1,105% +$27.1M 0.01% 504
2019
Q4
$2.41M Buy
60,951
+45,935
+306% +$1.82M ﹤0.01% 2191
2019
Q3
$102K Buy
+15,016
New +$102K ﹤0.01% 4257
2019
Q2
Sell
-26,133
Closed -$363K 5268
2019
Q1
$363K Buy
26,133
+6,360
+32% +$88.3K ﹤0.01% 3602
2018
Q4
$215K Sell
19,773
-30,928
-61% -$336K ﹤0.01% 3813
2018
Q3
$641K Sell
50,701
-45,926
-48% -$581K ﹤0.01% 3013
2018
Q2
$1.27M Buy
96,627
+77,798
+413% +$1.02M ﹤0.01% 2468
2018
Q1
$256K Sell
18,829
-38,294
-67% -$521K ﹤0.01% 3337
2017
Q4
$340K Buy
57,123
+10,744
+23% +$63.9K ﹤0.01% 3064
2017
Q3
$344K Buy
46,379
+33,871
+271% +$251K ﹤0.01% 2906
2017
Q2
$117K Sell
12,508
-11,580
-48% -$108K ﹤0.01% 3277
2017
Q1
$175K Sell
24,088
-17,406
-42% -$126K ﹤0.01% 3229
2016
Q4
$307K Buy
+41,494
New +$307K ﹤0.01% 2793
2016
Q3
Sell
-67,085
Closed -$301K 4233
2016
Q2
$301K Sell
67,085
-3,668
-5% -$16.5K ﹤0.01% 2550
2016
Q1
$176K Buy
70,753
+31,652
+81% +$78.7K ﹤0.01% 2750
2015
Q4
$316K Buy
+39,101
New +$316K ﹤0.01% 2682
2014
Q3
Sell
-7,857
Closed -$46K 3819
2014
Q2
$46K Buy
+7,857
New +$46K ﹤0.01% 3134